CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Planned sale GOLDSMITH MARK A sold 11,715 shares at $44.19 ($517,631)
- 4 Planned sale Chief Operating Officer sold 4,331 shares at $44.19 ($191,367)
- 4 Planned sale Kelsey Stephen Michael sold 4,665 shares at $44.19 ($206,124)
- 4 Planned sale General Counsel sold 1,454 shares at $44.19 ($64,245)
- 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at an average $43.32 ($722,087)
- 4 Returned to the company Director returned 1,808 shares (to the company)
- 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at $42.98 ($716,389)
- 4 Grant or award Director acquired 6,932 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale GOLDSMITH MARK A sold 10,000 shares at an average $45.88 ($458,827)
- 4 Planned sale Kelsey Stephen Michael sold 16,667 shares at an average $46.47 ($774,516)
- 4 Planned sale GOLDSMITH MARK A sold 35,000 shares at an average $45.04 ($1,576,322)
- 4 Planned sale General Counsel sold 2,399 shares at $40.83 ($97,951)
- 4 Planned sale Director sold 2,155 shares at $44.00 ($94,820)
- 4/A Grant or award Director acquired 4,248 shares (grant or award)
- 4/A Grant or award Director acquired 4,248 shares (grant or award)
- 4/A Grant or award Director acquired 4,248 shares (grant or award)
- 4/A Grant or award Director acquired 4,248 shares (grant or award)
- 4/A Grant or award Director acquired 4,248 shares (grant or award)
- 4/A Grant or award Director acquired 4,248 shares (grant or award)
Page 8 of 21 · 414 filings